12:00 AM
Feb 17, 2014
 |  BC Week In Review  |  Company News  |  Deals

Audion Therapeutics, Eli Lilly deal

Hearing loss company Audion received exclusive rights to undisclosed compounds from Eli Lilly in development to treat hearing loss via hair cell regeneration. Under the deal, Lilly has...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >